My comment was not specific to any company but to the entire HCV space, so to the extent that the overall hysteria has affected Medivir, I would think it's overvalued, but probably not as ridiculously as Pharmasset was. But this hysteria will likely last several more years - TMC-435 looks like a great drug and there will likely be many opportunities for MDVR shares to appreciate in the near term.
Market Data 
Markets 
AI
